课题基金 / 基金详情

The Clinical Utility and Ancestral Diversity of Polygenic Risk Scores in Cardiometabolic Disease Risk Prediction

The Clinical Utility and Ancestral Diversity of Polygenic Risk Scores in Cardiometabolic Disease Risk Prediction
多基因风险评分在心脏代谢疾病风险预测中的临床效用和祖先多样性
批准号:
495440
负责人:
Phulka Jobanjit S
金额:
$0.11万
依托单位国家:
加拿大
项目类别:
财政年份:
2023
资助国家:
加拿大
项目状态:
已结题
起止时间:
2023-09-01 至 2024-09-01

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
A polygenic risk score (PRS) estimates an individual’s genetic risk for a specific disease at birth. Cardiometabolic diseases have disproportionally affected underrepresented racial and minority groups. These groups are generally not well captured by trad
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金